The consensus molecular classification of muscle-invasive bladder cancer
Citations Over Time
Abstract
Abstract Muscle-Invasive Bladder Cancer (MIBC) is a molecularly diverse disease with heterogeneous clinical outcomes. Several molecular classifications have been proposed, yielding diverse sets of subtypes, which hampers the clinical implications of such knowledge. Here, we report the results of a large international effort to reach a consensus on MIBC molecular subtypes. Using 1750 MIBC transcriptomes and a network-based analysis of six independent MIBC classification systems, we identified a consensus set of six molecular classes: Luminal Papillary (24%), Luminal Non-Specified (8%), Luminal Unstable (15%), Stroma-rich (15%), Basal/Squamous (35%), and Neuroendocrine-like (3%). These consensus classes differ regarding underlying oncogenic mechanisms, infiltration by immune and stromal cells, and histological and clinical characteristics. This consensus system offers a robust framework that will enable testing and validating predictive biomarkers in future clinical trials.
Related Papers
- → Transcriptome analysis suggests mechanisms for a novel flowering type: Cleistogamous wheat(2020)12 cited
- → Gonadal transcriptomic analysis and identification of candidate sex-related genes in Mesocentrotus nudus(2019)22 cited
- → The evolution of the testis transcriptome in pregnant male pipefishes and seahorses(2022)7 cited
- → 2076 Prognostic factors in patients treated with a bladder sparing treatment for infiltranting bladder cancer(1996)
- → POS-02.22: Neoadjuvant low-dose chemoradiotherapy against muscle-invasive bladder cancer: Possible improvement of survival and favorable local control for bladder-preserved patients(2007)